Terms: = Melanoma AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
79 results:
1. Clinical, dermatoscopic, histological and molecular predictive factors of distant melanoma metastasis: A systematic review and meta-analysis.
Lallas K; Kyrgidis A; Chrysostomidis A; Vakirlis E; Apalla Z; Lallas A
Crit Rev Oncol Hematol; 2024 Oct; 202():104458. PubMed ID: 39074631
[TBL] [Abstract] [Full Text] [Related]
2. Review on radiomic analysis in
Amrane K; Meur CL; Thuillier P; Berthou C; Uguen A; Deandreis D; Bourhis D; Bourbonne V; Abgral R
Cancer Imaging; 2024 Jul; 24(1):87. PubMed ID: 38970050
[TBL] [Abstract] [Full Text] [Related]
3. melanoma Management: Exploring staging, Prognosis, and Treatment Innovations.
Shalata W; Attal ZG; Solomon A; Shalata S; Abu Saleh O; Tourkey L; Abu Salamah F; Alatawneh I; Yakobson A
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891988
[TBL] [Abstract] [Full Text] [Related]
4. Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma.
Indini A; Gueli R; Cerati M; Rijavec E; Parravicini M; Casagrande S; Rovelli C; Grossi PA; Grossi F
Melanoma Res; 2024 Aug; 34(4):386-389. PubMed ID: 38768445
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.
Roccuzzo G; Sarda C; Pala V; Ribero S; Quaglino P
Expert Rev Mol Diagn; 2024 May; 24(5):379-392. PubMed ID: 38738539
[TBL] [Abstract] [Full Text] [Related]
6. Dabrafenib plus trametinib in unselected advanced braf V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
7. Penile melanoma: a pathological report of two cases.
Pósfai B; Szentkereszty M; Sánta F; Bajory Z; Simon A; Kozéki Z; Csányi I; Akgul M; Kuthi L
Diagn Pathol; 2023 Oct; 18(1):117. PubMed ID: 37898793
[TBL] [Abstract] [Full Text] [Related]
8. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan.
Wu CE; Liao YH; Wu CL; Yen RF; Lin CC; Yang MH; Yen CC; Su WC; Yen CJ; Chang YF; Wu MF; Yang Y; Lin CY; Yang WC; Wang HC; Li CY; Ho YY; Chang YY; Wu CS; Hsu HC; Chen KH; Huang Y; Chen CJ; Chuang PJ; Lai YC; Huang YY; Tseng NC; Huang YT; Chu CY; Wen-Cheng Chang J
J Formos Med Assoc; 2024 Jan; 123(1):7-15. PubMed ID: 37690868
[TBL] [Abstract] [Full Text] [Related]
9. A diagrammatic summary of updated NICE melanoma guidance: A simple way to mitigate human factors in MDTs and clinics.
Chin YR; Dickson J
J Plast Reconstr Aesthet Surg; 2023 Jun; 81():85-87. PubMed ID: 37121047
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
11. Clinical predictors of survival in real world practice in stage IV melanoma.
Hu HP; Archer C; Yip D; Peters G
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1691. PubMed ID: 36161287
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
13. Sinonasal Mucosal melanoma: Role of Tumor Proliferative Indices and Pathological Factors in Survival.
Guo R; Jenkins SM; Johnson BJ; Reed K; Kroneman T; Choby G
Laryngoscope; 2022 Dec; 132(12):2350-2358. PubMed ID: 35661370
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Pathology of Skin melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction.
Tímár J; Ladányi A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628196
[TBL] [Abstract] [Full Text] [Related]
15. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.
Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Basset-Seguin N; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Forsea AM; Grob JJ; Hoeller C; Kaufmann R; Kelleners-Smeets N; Lallas A; Lebbé C; Lytvynenko B; Malvehy J; Moreno-Ramirez D; Nathan P; Pellacani G; Saiag P; Stratigos AJ; Van Akkooi ACJ; Vieira R; Zalaudek I; Lorigan P;
Eur J Cancer; 2022 Jul; 170():256-284. PubMed ID: 35623961
[TBL] [Abstract] [Full Text] [Related]
16. The "Great Debate" at melanoma Bridge 2021, December 2nd-4th, 2021.
Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
[TBL] [Abstract] [Full Text] [Related]
17. TMB and braf mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy.
Eckardt J; Schroeder C; Martus P; Armeanu-Ebinger S; Kelemen O; Gschwind A; Bonzheim I; Eigentler T; Amaral T; Ossowski S; Rieß O; Flatz L; Garbe C; Forschner A
J Cancer Res Clin Oncol; 2023 Feb; 149(2):833-840. PubMed ID: 35192052
[TBL] [Abstract] [Full Text] [Related]
18. Multimodality Imaging and Genetics of Primary Mucosal melanomas and Response to Treatment.
Saleh M; Javadi S; Elsherif S; Patnana M; Sagebiel TL; Torres-Cabala C; Mattei J; Bhosale P; Faria SC
Radiographics; 2021; 41(7):1954-1972. PubMed ID: 34678102
[TBL] [Abstract] [Full Text] [Related]
19. melanoma brain metastases that progress on braf-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
Lau PKH; Feran B; Smith L; Lasocki A; Molania R; Smith K; Weppler A; Angel C; Kee D; Bhave P; Lee B; Young RJ; Iravani A; Yeang HA; Vergara IA; Kok D; Drummond K; Neeson PJ; Sheppard KE; Papenfuss T; Solomon BJ; Sandhu S; McArthur GA
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625515
[TBL] [Abstract] [Full Text] [Related]
20. Multidisciplinary Care of braf-Mutant Stage III melanoma: A Physicians Perspective Review.
Cornelius LA; Fields RC; Tarhini A
Oncologist; 2021 Sep; 26(9):e1644-e1651. PubMed ID: 34080754
[TBL] [Abstract] [Full Text] [Related]
[Next]
